Intermittent Hypoxia in Persons With Multiple Sclerosis

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorShirley Ryan AbilityLab

About this trial

This study aims to understand the mechanisms of a novel intervention involving breathing short durations of low levels of oxygen for persons with multiple sclerosis (MS). This intervention with low levels of oxygen is called Acute Intermittent Hypoxia (AIH), the levels of oxygen experienced are similar to breathing the air on a tall mountain, for less than 1 minute at a time. Previous studies have shown that AIH is a safe and effective way to increase strength in persons with MS. Here the investigators aim to look at brain activation and ankle strength before and after AIH to gain a better understanding of how the AIH may improve strength in those persons with MS.

Eligibility criteria

Qualifiers

Diagnoses of relapsing form of MS (including relapsing-remitting MS and secondary-progressive MS)

Expanded Disability Status Scale (EDSS) score of at least 3 and no more than 6.5

Motor Functional System Scale (FSS) between 2-4

Relapse free for at least 1 year

Disqualifiers

Active contrast-enhancing MS lesions, or diffusion positive lesions suggestive of acute cerebrovascular disease on baseline MRI scan

Uncontrolled hypertension (Systolic between 85 and 140, diastolic between 90 and 55)

History of epilepsy

Chronic obstructive pulmonary disease

Trial design

Treatments tested in this trial

  • Acute Intermittent Hypoxia
  • Sham-Acute Intermittent Hypoxia

Treatment groups

21 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Shirley Ryan AbilityLab

Lead sponsor

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Collaborator

Northwestern University

Collaborator